# EDGAR Filing Document

**Accession Number:** 0001819253
**File Stem:** 0001193125-26-140105
**Filing Date:** 2026-4
**Character Count:** 5545
**Document Hash:** 542bc9627fda14908bb2fb490d28ca59
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-140105.hdr.sgml**: 20260402

**ACCESSION NUMBER**: 0001193125-26-140105

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 9

**FILED AS OF DATE**: 20260402

**DATE AS OF CHANGE**: 20260402

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** biote Corp.
- **CENTRAL INDEX KEY:** 0001819253
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 851791125
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40128
- **FILM NUMBER:** 26833579

**BUSINESS ADDRESS:**
- **STREET 1:** 1875 W. WALNUT HILL LN #100
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75038
- **BUSINESS PHONE:** 972-486-9346

**MAIL ADDRESS:**
- **STREET 1:** 1875 W. WALNUT HILL LN #100
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75038

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Haymaker Acquisition Corp. III
- **DATE OF NAME CHANGE:** 20200727

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**SCHEDULE 14A** 

**Proxy Statement Pursuant to Section 14(a) of the** 

**Securities Exchange Act of 1934** 

**(Amendment No.)** 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))**

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material Pursuant to § 240.14a-12

## BIOTE CORP.
**(Name of Registrant as Specified In Its Charter)** 

**(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)** 

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required.

☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

------

---

| | |
|:---|:---|
| ![LOGO](g42219dsp2.jpg) | ![LOGO](g42219dsp004.jpg) |

---

---

| | | |
|:---|:---|:---|
| **biote Corp.**<br>**Annual Meeting of Stockholders**<br>Tuesday, May 12, 2026 10:00 AM, Central Time<br>Annual Meeting to be held live via the internet - please visit www.proxydocs.com/BTMD for more details.<br>**You must register to attend the Annual Meeting online and/or participate at www.proxydocs.com/BTMD**<br>**For a convenient way to view proxy materials, VOTE, and obtain directions to attend the meeting go to www.proxydocs.com/BTMD**<br>**To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.**<br>This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.<br>Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet.<br>If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before May 1, 2026.<br>| ![LOGO](g42219dsp3d.jpg) <br>| <br>**Meeting Materials:** Notice of Meeting and Proxy Statement & Annual Report on Form 10-K<br>**Important Notice Regarding the Availability of Proxy Materials for the Stockholders' Meeting To Be Held On May 12, 2026 For Stockholders of record as of March 23, 2026**<br>**To order paper materials, use one of the following methods.**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ![LOGO](g42219dsp004b.jpg) <br>**Internet:**<br> **www.investorelections.com/BTMD**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ![LOGO](g42219dsp004c.jpg) <br> **Call:**<br> **1-866-648-8133**<br>![LOGO](g42219snap1.jpg) <br> **Email:**<br> **paper@investorelections.com**<br>\* If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material.<br>![LOGO](g42219dsp3ejpg.jpg)  |
|  |  | Have the 12 digit control number located in the box above available when you access the website and follow the instructions. |
| **SEE REVERSE FOR FULL AGENDA** |  |  |

---

Copyright© 2026 BetaNXT, Inc. or its affiliates. All Rights Reserved

------

---

| | |
|:---|:---|
| ![LOGO](g42219dsp005.jpg) | **biote Corp. Annual Meeting of Stockholders** |

---

**THE BOARD OF DIRECTORS RECOMMENDS A VOTE:** 

**FOR** ALL NOMINEES FOR DIRECTOR IN PROPOSAL 1 AND **FOR** PROPOSAL 2

 <br> **PROPOSAL**<br>

---

| | |
|:---|:---|
| 1. | To elect two Class I directors, each to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal; |
|  | 1.01 Andrew R. Heyer |
|  | 1.02 Dana Jacoby |
| 2. | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; |
|  | NOTE: To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof. |

---